发明名称 |
Ipamorelin diacetate injection and infusion solutions |
摘要 |
596641 Disclosed is an injection or infusion solution of Ipamorelin comprising: a) ipamorelin solubilized by approximately two molar equivalents of acetic acid (ipamorelin diacetate), in an amount of from 0.001 to 20%, based on the weight of the free base of ipamorelin; b) a molar excess of acid, preferably acetic acid, in an amount sufficient to give a pH of at least 4 and less than 6.5; c) optionally from 0.1 to 30% of one or more formulation aids; and d) water q.s. to 100%; all percentages based on the total weight of the solution. Also disclosed are methods for the production of such a solution. |
申请公布号 |
NZ596641(A) |
申请公布日期 |
2013.12.20 |
申请号 |
NZ20100596641 |
申请日期 |
2010.05.27 |
申请人 |
HELSINN THERAPEUTICS (U.S.) INC. |
发明人 |
RUBIO SILVINA GARCIA;WEIBEL HELLE;BRAGLIA RICCARDO;BEIDLER DANIEL |
分类号 |
A61K9/08;A61K9/00;A61K38/25;A61K47/12 |
主分类号 |
A61K9/08 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|